The mechanism of action of valsartan studied by HPLC-TOF/MS.
- Author:
Wenqing YANG
;
Yunlun LI
;
Haiqiang JIANG
- Publication Type:Journal Article
- From:
Acta Pharmaceutica Sinica
2015;50(7):875-81
- CountryChina
- Language:Chinese
-
Abstract:
High performance liquid chromatography-time-off-flight mass spectrometer (HPLC-TOFMS) technology coupled with partial least squares discriminant analysis (PLS-DA) processed by SIMCA-P software was applied to investigate serum endogenous metabolites alternations of valsartan in spontaneous hypertension rats (SHR). And MetPA platform was used to connect identified potential biomarkers in corresponding metabolic pathways to find possible therapeutic mechanism of valsartan. Valsartan significantly declined the blood pressure of SHRs (P < 0.05) at fourth week. The metabolic profiling significantly changed and four metabolites involved in G protein-coupled pathway were identified. Metabolomics is able to detect holistic and microcosmic alternations in organism, so as to elucidate therapeutic mechanism of drugs.
